Germinal vesicle material drives meiotic cell cycle of mouse oocyte through the 3'UTR-dependent control of cyclin B1 synthesis.
We compared the profile of histone H1 kinase activity, reflecting Maturation Promoting Factor (MPF) activity in oocytes bisected at the germinal vesicle (GV) stage and allowed to mature as separate oocyte halves in vitro. Whereas the oocyte halves containing the nucleus exhibited the same profile of increased kinase activity as that typical for intact oocytes, the anuclear halves revealed strong inhibition of the increase in this activity soon after germinal vesicle breakdown (GVBD). In contrast, the profile of MAP kinase activity did not differ significantly between anuclear and nucleus-containing oocyte halves throughout maturation. Of the two MPF components, CDK1 and cyclin B1, the amount of the latter was significantly reduced in anuclear halves, a reduction due to low-level synthesis and not to enhanced degradation. Expression of three reporter luciferase RNAs constructed, respectively, to contain cyclin B1-specific 3'UTR, the globin-specific 3'UTR, or no 3'UTR sequence was enhanced in nuclear halves, with significantly greater enhancement for the construct containing cyclin B1-specific 3'UTR as compared to the two other RNAs. We conclude that the profile of activity of MPF during mouse oocyte maturation is controlled by an unknown GV-associated factor(s) acting via 3'UTR-dependent control of cyclin B1 synthesis. These results require the revision of the hitherto prevailing view that the control of MPF activity during mouse oocyte maturation is independent of GV-derived material.
Department of Developmental Biology, Max Planck Institute of Immunobiology, Stuebeweg 51, 79-108 Freiburg, Germany.
Steffen
S
Hoffmann
Chizuko
C
Tsurumi
Jacek Z
JZ
Kubiak
Zbigniew
Z
Polanski
D020413:3' Untranslated Regions / Q000502:physiology*; D000818:Animals; D016203:CDC2 Protein Kinase / Q000235:genetics / Q000378:metabolism; D002467:Cell Nucleus / Q000201:enzymology / Q000235:genetics / Q000502:physiology*; D002478:Cells, Cultured; D019926:Cyclin B / Q000096:biosynthesis* / Q000235:genetics*; D056744:Cyclin B1; D005260:Female; D018507:Gene Expression Regulation, Developmental; D016200:Maturation-Promoting Factor / Q000378:metabolism; D008540:Meiosis / Q000235:genetics; D000090204:Mesothelin; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009865:Oocytes / Q000201:enzymology / Q000502:physiology*; D011494:Protein Kinases / Q000378:metabolism; D017231:Proto-Oncogene Proteins c-mos / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis
D020413:3' Untranslated Regions; C534700:Ccnb1 protein, mouse; D019926:Cyclin B; D056744:Cyclin B1; C000715528:Msln protein, mouse; D012333:RNA, Messenger; D011494:Protein Kinases; C102333:histone H1 kinase; D017231:Proto-Oncogene Proteins c-mos; D016203:CDC2 Protein Kinase; D016200:Maturation-Promoting Factor; D020928:Mitogen-Activated Protein Kinases; D000090204:Mesothelin